Panbela Therapeutics, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2012 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Panbela Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2012 to Q1 2024.
  • Panbela Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $7.08M, a 48.3% decline year-over-year.
  • Panbela Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $26.1M, a 388% increase from 2022.
  • Panbela Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $5.35M, a 47% decline from 2021.
  • Panbela Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $10.1M, a 3.33% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $7.08M -$6.62M -48.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q1 2023 $13.7M +$13.7M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2022 $0 -$1.04M -100% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q1 2021 $1.04M +$1.07M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 -$26K -$784K -103% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q1 2019 $758K -$853K -52.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q1 2018 $1.61M -$1.46M -47.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q1 2017 $3.07M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q1 2015 -$21.5K -$19.3K Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-15
Q1 2014 -$2.22K* +$954 Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q1 2013 -$3.17K -$12.3K -135% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q1 2012 $9.15K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.